Echosens

Echosens is a French company that specializes in non-invasive medical devices for the diagnosis and monitoring of chronic liver diseases. The company's flagship product, the FibroScan, is a non-invasive device that uses patented Vibration-Controlled Transient Elastography (VCTE) to measure liver stiffness and ultrasound attenuation for steatosis quantification. This technology provides a quantitative assessment of liver fibrosis and steatosis, which are key markers of liver health.

The company's business model is based on the sale of its FibroScan devices and related consumables to hospitals, clinics, and research institutions worldwide. Echosens also offers a range of services, including training, technical support, and clinical research support, to its customers. The company's target market includes hepatologists, gastroenterologists, and other healthcare professionals involved in the diagnosis and management of liver diseases.

Echosens has a global presence, with offices in Europe, North America, and Asia. The company's products are sold in over 100 countries, and it has a strong network of distributors and partners. Echosens is a well-established player in the liver disease diagnostics market, and its products are widely recognized for their accuracy, reliability, and ease of use.

Keywords: medical devices, liver disease, diagnostics, non-invasive, FibroScan, VCTE, hepatology, gastroenterology, healthcare, medical technology